|
Market Closed -
Nasdaq
23:00:00 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.310 USD | +3.15% |
|
-7.09% | +18.02% |
| Market Cap | 37.92M 33.07M 31.22M 28.35M 53.12M 3.64B 53.34M 374M 144M 1.85B 142M 139M 5.95B | P/E 2024 |
-0.79x | P/E 2025 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 106M 92.83M 87.65M 79.6M 149M 10.22B 150M 1.05B 405M 5.19B 400M 391M 16.71B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 3.77x |
| Free-Float |
62.82% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CELU | Delayed | |
CBOE
| CELU | Real-time |
| 1 day | +3.15% | ||
| 1 week | -7.09% | ||
| Current month | -29.19% | ||
| 1 month | +70.80% | ||
| 3 months | +74.13% | ||
| 6 months | +7.38% | ||
| Current year | +18.02% |
| 1 week | 1.21 |  | 1.4 |
| 1 month | 0.75 | | 2.55 |
| Current year | 0.56 | | 2.55 |
| 1 year | 0.56 | | 2.55 |
| 3 years | 0.56 | | 7.97 |
| 5 years | 0.56 | | 131.86 |
| 10 years | 0.56 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 01/01/2016 | |
John Sprague
DFI | Director of Finance/CFO | 67 | 27/02/2026 |
K Fletcher
CMP | Compliance Officer | 42 | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 01/01/2016 | |
Peter Diamandis
BRD | Director/Board Member | 64 | 01/07/2017 |
Diane Parks
BRD | Director/Board Member | 73 | 03/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/13/26 A | Exercice | Chief Administrative Officer | 3,865 | 0.0134% | ||
| 4/13/26 A | Exercice | Executive/Senior Manager | 1,910 | 0.0066% | ||
| 4/13/26 A | Exercice | Chief Executive Officer | 7,744 | 0.0269% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.15% | -7.09% | -40.99% | -43.04% | 37.92M | |
| -0.58% | +0.43% | +32.58% | -5.62% | 78.37B | |
| -2.55% | +6.99% | +510.30% | +48.79% | 61.5B | |
| +1.54% | +3.92% | -10.51% | -30.45% | 59.78B | |
| +0.14% | -1.20% | -11.21% | +26.46% | 46.53B | |
| +0.77% | -0.38% | +1.55% | +152.10% | 45.5B | |
| -1.62% | -0.76% | +51.23% | -17.28% | 31.84B | |
| -1.81% | +3.16% | +44.82% | +107.57% | 25.4B | |
| +6.00% | +5.73% | +8.13% | +170.18% | 21.43B | |
| -0.40% | -1.12% | +57.39% | +103.30% | 15.77B | |
| Average | +0.46% | +0.76% | +64.33% | +51.20% | 38.62B | |
| Weighted average by Cap. | -0.11% | +1.56% | +95.05% | +42.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 54.22M 47.28M 44.64M 40.54M 75.95M 5.2B 76.27M 535M 206M 2.65B 204M 199M 8.51B | 26.55M 23.15M 21.86M 19.85M 37.19M 2.55B 37.35M 262M 101M 1.3B 99.74M 97.52M 4.17B |
| Net income | -57.89M -50.48M -47.67M -43.28M -81.1M -5.56B -81.44M -571M -220M -2.82B -217M -213M -9.09B | -91.72M -79.98M -75.52M -68.57M -128M -8.8B -129M -905M -349M -4.47B -345M -337M -14.4B |
| Net Debt | 68.1M 59.38M 56.07M 50.92M 95.4M 6.53B 95.79M 672M 259M 3.32B 256M 250M 10.69B | 68.54M 59.77M 56.43M 51.24M 96.01M 6.58B 96.41M 676M 261M 3.34B 257M 252M 10.76B |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $1.310 | +3.15% | 188,400 |
| 17/09/26 | $1.270 | -1.55% | 77,758 |
| 16/09/26 | $1.290 | +4.03% | 181,095 |
| 15/09/26 | $1.240 | -11.43% | 149,414 |
| 14/09/26 | $1.400 | -0.71% | 206,968 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CELU Stock
Select your edition
All financial news and data tailored to specific country editions
